Effect of eslicarbazepine acetate and oxcarbazepine on cognition and psychomotor function in healthy volunteers.
The results of two single-blind studies conducted to evaluate the cognitive and psychomotor effects of eslicarbazepine acetate and oxcarbazepine following single and repeated administration in healthy volunteers are reported. The cognitive and psychomotor evaluation consisted of several computerized and paper-and-pencil measures. Eslicarbazepine acetate and oxcarbazepine had similar overall cognitive profiles and did not cause clinically relevant cognitive impairment. The incidence of adverse events was lower with eslicarbazepine acetate than with oxcarbazepine.
Milovan
Denise
D
Kendle Early Stage, Toronto, ON, Canada.
Almeida
Luis
L
Romach
Myroslava K
MK
Nunes
Teresa
T
Rocha
José Francisco
JF
Sokowloska
Marta
M
Sellers
Edward M
EM
Soares-da-Silva
Patrício
P
D000328:Adult; D000927:Anticonvulsants / Q000494:pharmacology*; D001288:Attention / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D002220:Carbamazepine / Q000031:analogs & derivatives* / Q000494:pharmacology; D003071:Cognition / Q000187:drug effects*; D003984:Dibenzazepines / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005500:Follow-Up Studies; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007858:Learning / Q000187:drug effects; D008875:Middle Aged; D009483:Neuropsychological Tests; D000078330:Oxcarbazepine; D011597:Psychomotor Performance / Q000187:drug effects*; D011930:Reaction Time / Q000187:drug effects; D016037:Single-Blind Method; D018709:Statistics, Nonparametric; D055815:Young Adult
D000927:Anticonvulsants; D003984:Dibenzazepines; D002220:Carbamazepine; C416835:eslicarbazepine acetate; D000078330:Oxcarbazepine